Physician profile
Jillian Gartland
NPI 1245825322
$3,778.39
in general payments reported to CMS, 2019-2025
11 companies · $2,098 in 2025
The $2,098 reported for 2025 was more than what 98% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,680 · 2025: $2,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,778.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,117.62 | 2024-2025 | Sotyktu |
| Abbvie INC. | $741.42 | 2024-2025 | |
| Genzyme Corporation | $572.95 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $402.19 | 2024-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $239.36 | 2024-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $229.67 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Leo Pharma INC. | $204.78 | 2024-2025 | Anzupgo, Adbry |
| Sun Pharmaceutical Industries INC. | $180.88 | 2025 | |
| Galderma Laboratories, L.P. | $41.87 | 2025 | Aklief |
| Amgen INC. | $27.14 | 2025 | Otezla |
| Organon LLC | $20.51 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Gartland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.